What Black Diamond Therapeutics Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 2 | 8 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 14,508 | 54,273 |
| Disposed | 0 | 0 |
| Net activity | +14,508 | +54,273 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Raman Prakash | Director | Sep 18 | Grant / award · A | +6,801 | $1.93 | +$13.1K | 51,840 |
| Behbahani Ali | Director | Sep 18 | Grant / award · A | +7,707 | $1.93 | +$14.9K | 110,236 |
| Behbahani Ali | Director | Jun 19 | Grant / award · A | +8,961 | $1.66 | +$14.9K | 102,529 |
| Raman Prakash | Director | Jun 19 | Grant / award · A | +7,907 | $1.66 | +$13.1K | 45,039 |
| Behbahani Ali | Director | Mar 20 | Grant / award · A | +6,919 | $2.15 | +$14.9K | 93,568 |
| Raman Prakash | Director | Mar 20 | Grant / award · A | +6,105 | $2.15 | +$13.1K | 37,132 |
| Behbahani Ali | Director | Dec 12 | Grant / award · A | +5,208 | $2.76 | +$14.4K | 86,649 |
| Raman Prakash | Director | Dec 12 | Grant / award · A | +4,665 | $2.76 | +$12.9K | 31,027 |
| Behbahani Ali | Director | Sep 19 | Grant / award · A | +4,291 | $3.35 | +$14.4K | 81,441 |
| Raman Prakash | Director | Sep 19 | Grant / award · A | +3,843 | $3.35 | +$12.9K | 26,362 |
| Behbahani Ali | Director | Jun 20 | Grant / award · A | +6,170 | $2.33 | +$14.4K | 77,150 |
| Raman Prakash | Director | Jun 20 | Grant / award · A | +5,526 | $2.33 | +$12.9K | 22,519 |
| Behbahani Ali | Director | Mar 21 | Grant / award · A | +7,646 | $1.88 | +$14.4K | 70,980 |
| Raman Prakash | Director | Mar 21 | Grant / award · A | +6,848 | $1.88 | +$12.9K | 16,993 |
| Biotech Growth N V | 10% owner | Mar 19 | Open-market sale · S | −500,000 | $2.12 | −$1.06M | 2,733,547 |
| Biotech Growth N V | 10% owner | Mar 19 | Open-market sale · S | −584,292 | $1.95 | −$1.14M | 3,233,547 |
| Biotech Growth N V | 10% owner | Mar 19 | Open-market sale · S | −400,000 | $2.09 | −$837K | 3,817,839 |
| Biotech Growth N V | 10% owner | Mar 19 | Open-market sale · S | −2,000,000 | $2.00 | −$4M | 4,217,839 |
| Biotech Growth N V | 10% owner | Mar 19 | Open-market sale · S | −1,000,000 | $2.31 | −$2.31M | 6,217,839 |
| Biotech Growth N V | 10% owner | Mar 19 | Open-market sale · S | −300,000 | $1.94 | −$583K | 7,217,839 |
Loading...
